107 related articles for article (PubMed ID: 12501825)
1. No nukes please.
TreatmentUpdate; 2002 Nov; 14(8):6. PubMed ID: 12501825
[No Abstract] [Full Text] [Related]
2. Focus on fat.
TreatmentUpdate; 2002 Nov; 14(8):4. PubMed ID: 12501822
[No Abstract] [Full Text] [Related]
3. Lipodystrophy--nukes vs. protease inhibitors.
TreatmentUpdate; 2001 Jul; 13(3):5-6. PubMed ID: 11569989
[No Abstract] [Full Text] [Related]
4. Pathogenesis of HIV-associated lipodystrophy.
Wanke C
AIDS Clin Care; 2000 Dec; 12(12):100. PubMed ID: 12211161
[No Abstract] [Full Text] [Related]
5. Popping pills for life.
Focus; 1998 Feb; 13(3):5-6. PubMed ID: 11365169
[TBL] [Abstract][Full Text] [Related]
6. Buffalo hump: what the experts suggest.
Piliero PJ; McComsey GA
AIDS Clin Care; 2004 Mar; 16(3):22-3. PubMed ID: 15119294
[No Abstract] [Full Text] [Related]
7. Anti-HIV agents. Atazanavir as a booster for protease inhibitors.
TreatmentUpdate; 2003; 15(4):1-2. PubMed ID: 17216850
[No Abstract] [Full Text] [Related]
8. Efficacy and safety of once-daily antiretroviral therapy.
Boyle BA
AIDS Read; 2002 Mar; 12(3):90-2, 95-6, 109. PubMed ID: 11966243
[No Abstract] [Full Text] [Related]
9. Anti-HIV agents. Atazanavir and saquinavir.
TreatmentUpdate; 2004; 16(3):9-10. PubMed ID: 17219610
[No Abstract] [Full Text] [Related]
10. How HIV drugs work 101.
Pietrandoni G
Posit Aware; 2001; 12(5):26-7. PubMed ID: 11688481
[No Abstract] [Full Text] [Related]
11. Editorial comment: tenofovir-related nephrotoxicity--who's at risk?
Gupta Samir K
AIDS Read; 2007 Feb; 17(2):102-3. PubMed ID: 17323509
[No Abstract] [Full Text] [Related]
12. [Enduringly effective and tolerable initial therapy of HIV. Even after 5 years no resistance].
MMW Fortschr Med; 2003 Dec; 145(50):60-1. PubMed ID: 14963980
[No Abstract] [Full Text] [Related]
13. Protease inhibitors in children: combination therapy reduced death by two thirds.
James JS
AIDS Treat News; 2001 Nov; (374):4-5. PubMed ID: 11775935
[No Abstract] [Full Text] [Related]
14. The ever-changing HIV treatment landscape.
Berger DS
Posit Aware; 2003; 14(1):69-70, 76. PubMed ID: 12630378
[No Abstract] [Full Text] [Related]
15. Antiretroviral drugs and the risk of myocardial infarction.
Zangerle R; Sarcletti M
N Engl J Med; 2007 Aug; 357(7):715-6; author reply 716-7. PubMed ID: 17703532
[No Abstract] [Full Text] [Related]
16. Updated guidelines for occupational postexposure prophylaxis.
del Rio C
AIDS Clin Care; 2005 Dec; 17(12):114. PubMed ID: 16388540
[No Abstract] [Full Text] [Related]
17. ABC in the news.
Carter M
IAPAC Mon; 2006 Jun; 12(6):178-9. PubMed ID: 17233104
[No Abstract] [Full Text] [Related]
18. Teaching adherence to substance users.
TreatmentUpdate; 2002; 14(4):4-5. PubMed ID: 12064315
[No Abstract] [Full Text] [Related]
19. HIV integrase inhibitors show potent activity in clinical trials.
Winslow DL
AIDS Alert; 2007 Jan; 22(1):10-1. PubMed ID: 17722343
[No Abstract] [Full Text] [Related]
20. Simplifying suppression: switching therapies to improve HIV disease management.
Moyle GJ
AIDS Read; 2004 Jul; 14(7):380-4. PubMed ID: 15282867
[No Abstract] [Full Text] [Related]
[Next] [New Search]
